Hand MOtor Rehabilitation Using a EMG-biofeedback: a Cross-sectional Study
Launched by IRCCS SAN CAMILLO, VENEZIA, ITALY · May 14, 2021
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
The aims of this study are to determine safety and feasibility of a prototype EMG-control wearable device (REMO) and to individualise clinical features of stroke survivors able to control the EMG armband targeted to hand rehabilitation.
The device REMO consists in an armband composed by 8 bipolar electrodes able to record and process the electromyography of forearm muscles. The patterns of muscle activations are classified and used to perform EMG-biofeedback exercises in stroke rehabilitation training. The device is developed by clinicians of IRCCS San Camillo Hospital and spin-off Morecog...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Single ischemic or haemorrhagic stroke;
- • Score lower than 100 out of a total of 126 at the Functional Independence Measure (FIM) scale
- Exclusion Criteria:
- • Untreated epilepsy;
- • Major depressive disorder;
- • Fractures;
- • Traumatic Brain Injurj;
- • Severe Ideomotor Apraxia;
- • Severe Neglect;
- • Severe impairment of verbal comprehension.
About Irccs San Camillo, Venezia, Italy
IRCCS San Camillo, located in Venice, Italy, is a renowned clinical research institute dedicated to advancing medical science through innovative research and high-quality clinical trials. As a recognized Institute of Hospitalization and Care for Scientific Research (IRCCS), it specializes in various fields, including neurology, psychiatry, and rehabilitation. With a commitment to improving patient outcomes, IRCCS San Camillo collaborates with national and international research networks, fostering a multidisciplinary approach to healthcare challenges. The institute emphasizes ethical standards and patient safety, ensuring that all trials adhere to rigorous regulatory guidelines while contributing valuable insights to the medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Venice Lido, Venice, Italy
Patients applied
Trial Officials
Andrea Turolla, PhD
Principal Investigator
IRCCS San Camillo Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials